Want to see TSE:CSCI full AI Analyst Report?
COSCIENS Biopharma (CSCI) Financial Statements
COSCIENS Biopharma Financial Overview
COSCIENS Biopharma's market cap is currently $8.37M. The company's EPS TTM is $-13.03; its P/E ratio is -0.46; COSCIENS Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.63M | $ 9.59M | $ 4.50M | $ 14.57M | $ 5.26M |
| Gross Profit | $ 2.69M | $ 4.73M | $ 4.28M | $ 8.56M | $ 5.17M |
| Operating Income | $ -10.62M | $ -14.02M | $ -18.01M | $ -15.38M | $ -8.67M |
| EBITDA | $ -9.41M | $ -13.49M | $ -16.57M | $ -13.91M | $ 2.85M |
| Net Income | $ -10.54M | $ -15.31M | $ -3.55M | $ 3.24M | $ 2.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.29M | $ 16.39M | $ 34.02M | $ 50.61M | $ 65.30M |
| Total Assets | $ 21.39M | $ 35.07M | $ 37.02M | $ 56.03M | $ 80.10M |
| Total Debt | $ 2.15M | $ 2.31M | $ 3.39M | $ 3.86M | $ 4.16M |
| Net Debt | $ -5.15M | $ -14.08M | $ -4.94M | $ -46.75M | $ -65.14M |
| Total Liabilities | $ 17.56M | $ 21.91M | $ 18.82M | $ 20.25M | $ 27.12M |
| Stockholders' Equity | $ 3.84M | $ 13.16M | $ 18.20M | $ 35.78M | $ 52.99M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.34M | $ -15.73M | $ -17.14M | $ -13.69M | $ -9.22M |
| Operating Cash Flow | $ -8.62M | $ -14.57M | $ -17.12M | $ -13.68M | $ -8.58M |
| Investing Cash Flow | $ -466.02K | $ 25.08M | $ 528.00K | $ -12.00K | $ -658.00K |
| Financing Cash Flow | $ -414.12K | $ -588.00K | $ -151.00K | $ -118.00K | $ 51.04M |
Currency in USD